Related Experiment Video
Updated: Nov 2, 2025

05:05
Ultrasound Cyclo Plasty in Eyes with Glaucoma
Published on: January 26, 2018
12.4K
MicroPulse® Transscleral Laser Therapy - Fluence May Explain Variability in Clinical Outcomes: A Literature Review
Tomas M Grippo1,2, Facundo G Sanchez1,3, Joan Stauffer4
1Department of Glaucoma, Grippo Glaucoma & Cataract Center, Buenos Aires, Argentina.
Clinical Ophthalmology (Auckland, N.Z.)
|June 17, 2021
Summary
MicroPulse® Transscleral Laser Therapy (MP-TLT) efficacy varies due to inconsistent parameters. Fluence, a new dose metric, may improve outcome prediction and treatment optimization for MP-TLT.
Area of Science:
- Ophthalmology
- Medical Technology
- Laser Therapy
Background:
- MicroPulse® Transscleral Laser Therapy (MP-TLT) has been used since 2010.
- Varied treatment parameters lead to inconsistent clinical outcomes (intraocular pressure reduction, success rate, durability, safety).
- Difficulty in comparing studies and optimizing MP-TLT parameters due to underreported data.
Purpose of the Study:
- To analyze the impact of exposure time and sweep velocity on energy delivery in MP-TLT.
- To introduce fluence as a standardized "dose" metric for MP-TLT.
- To evaluate fluence as a potentially superior indicator of clinical outcomes compared to total energy.
Main Methods:
- Review and analysis of MP-TLT treatment parameters reported in the literature.
- Explanation of the relationship between exposure time, sweeps per hemisphere (sweep velocity), and energy delivery.
- Introduction and conceptualization of fluence as a unified dose metric.
Main Results:
- Exposure time and sweep velocity significantly influence energy delivery to the eye.
- These critical parameters are often underreported, hindering reproducibility and comparison.
- Fluence is proposed as a comprehensive metric combining all relevant treatment parameters.
Conclusions:
- Standardizing MP-TLT parameters is crucial for consistent clinical outcomes.
- Fluence offers a more reliable measure of light dose than total energy for MP-TLT.
- Adoption of fluence could enhance the predictability and comparability of MP-TLT research and practice.
Related Concept Videos
Angle Closure Glaucoma: Treatment
905
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
905
Open Angle Glaucoma: Treatment
778
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
778

